Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 28, 2009The Journal of Clinical Endocrinology & MetabolismOpen Access

Vildagliptin Enhances Islet Responsiveness to Both Hyper- and Hypoglycemia in Patients with Type 2 Diabetes

View Full Paper
Ask AI
Bookmark
Share

Authors

BÅBo ÅhrénASAnja SchweizerSDS. Dejager

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Åhrén et al. (2009) studied this question.

synapsesocial.com/papers/6a7135e184cc45bb7bdfe710https://doi.org/10.1210/jc.2008-2152
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Inhibition of Dipeptidyl Peptidase-4 Reduces Glycemia, Sustains Insulin Levels, and Reduces Glucagon Levels in Type 2 Diabetes2004 · 714 citations
  2. 2The Dipeptidyl Peptidase IV Inhibitor Vildagliptin Suppresses Endogenous Glucose Production and Enhances Islet Function after Single-Dose Administration in Type 2 Diabetic Patients2007 · 242 citations
  3. 3Sensory nerves contribute to insulin secretion by glucagon-like peptide-1 in mice2004 · 100 citations
  4. 4Effects of vildagliptin on glucose control in patients with type 2 diabetes inadequately controlled with a sulphonylurea*2008 · 233 citations
  5. 5Vagal, Cholinergic Regulation of Pancreatic Polypeptide Secretion1978 · 390 citations